HARI TUNUGUNTLA to Cardiomyopathies
This is a "connection" page, showing publications HARI TUNUGUNTLA has written about Cardiomyopathies.
Connection Strength
1.212
-
Ventricular assist device support for children with chemotherapy-induced cardiomyopathy and advanced heart failure: Perspectives gained from a single-center experience. Pediatr Transplant. 2022 08; 26(5):e14286.
Score: 0.548
-
Nonsense Variant PRDM16-Q187X Causes Impaired Myocardial Development and TGF-? Signaling Resulting in Noncompaction Cardiomyopathy in Humans and Mice. Circ Heart Fail. 2023 12; 16(12):e010351.
Score: 0.154
-
Arrhythmogenic cardiomyopathy is under-recognized in end-stage pediatric heart failure: A 36-year single-center experience. Pediatr Transplant. 2023 03; 27(2):e14442.
Score: 0.143
-
Current Practices in Treating Cardiomyopathy and Heart Failure in Duchenne Muscular Dystrophy (DMD): Understanding Care Practices in Order to Optimize DMD Heart Failure Through ACTION. Pediatr Cardiol. 2022 Jun; 43(5):977-985.
Score: 0.134
-
Amino Acid-Level Signal-to-Noise Analysis Aids in Pathogenicity Prediction of Incidentally Identified TTN-Encoded Titin Truncating Variants. Circ Genom Precis Med. 2021 02; 14(1):e003131.
Score: 0.124
-
Centrifugal-flow ventricular assist device support in children: A single-center experience. J Thorac Cardiovasc Surg. 2019 04; 157(4):1609-1617.e2.
Score: 0.109